LV Strain Superiority Over LVEF in HFmrEF: Is the Job Done After David’s Victory Over Goliath?∗
Corresponding Author
Related Articles
Dietary restriction impacts health and lifespan of genetically diverse mice
Nature – Health effects of dietary restriction are uncoupled from longevity.
HeartTalk Video: Navigating Remote Monitoring in an Evolving Cardiac Care Landscape
MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s premier source for organizational performance solutions.
Special Collection : Obesity | JACC
Advances in obesity medicine are reshaping the science and practice of cardiology. JACC’s new comprehensive hub highlights the latest research, commentary, and multimedia, including a…
The Effect of Semaglutide on Mortality and COVID-19–Related Deaths: An Analysis From the SELECT Trial
AbstractBackgroundPatients with overweight and obesity are at increased risk of death from multiple causes, including cardiovascular (CV) death, with few therapies proven to reduce the…
Semaglutide Improves CV Outcomes in Patients With History of CABG and Obesity | JACC | AHA 2024
JACC Associate Editor Marc P. Bonaca, MD, FACC, speaks with author Subodh Verma, MD, PhD, and A. Michael A. Lincoff, MD, FACC, about this brief…
Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity:
Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael’s Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada ∗Address for correspondence:…
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT): Outcomes by Sex
St Michael’s Hospital and University of Toronto, Toronto, Ontario, Canada ∗Address for correspondence: Dr Subodh Verma, St Michael’s Hospital, 30 Bond Street, University of Toronto,…
No One Talks about Vasoplegia
This webinar will discuss pathophysiology of vasoplegia and its implications in the management of patients receiving short and long-term mechanical circulatory support. Finally, we will…
The Extravascular Implantable Cardioverter-Defibrillator: A Promising Novel Device – American College of Cardiology
The extravascular implantable cardioverter-defibrillator (EV-ICD) effectively terminates ventricular arrhythmias and can be implanted safely. The substernal position of the EV-ICD lead allows for antitachycardia pacing…
Valve Disease and HCM: Predicting and Preventing Complications
Podcast Episode · In the Thick of It · 01/08/2025 · 33m
